Feedback / Questions
silevertinib (BDTX-1535) - Black Diamond Therap
https://www.globenewswire.com/news-release/2026/05/19/3297411/0/en/Black-Diamond-Therapeutics-to-Host-Webcast-for-Investors-Highlighting-Updated-Results-from-Phase-2-Trial-of-Silevertinib-in-1L-EGFRm-NSCLC.html
May 19, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next